의료용 신발 시장 : 기회, 성장 촉진요인, 산업 동향 분석(2025-2034년)

The Global Medical Footwear Market was valued at USD 10.7 billion in 2024, with projections to grow at a robust CAGR of 6.4% from 2025 to 2034. The market growth can be attributed to the rising incidence of foot-related conditions such as plantar fasciitis, bunions, and diabetic foot ulcers, which are driving a surge in demand for specialized footwear. As more individuals seek relief from painful foot ailments, medical footwear has become an essential part of their daily lives. Technological advancements are also contributing to market expansion, with innovations like 3D printing, smart insoles, and eco-friendly materials improving the design and functionality of medical footwear.

These technological breakthroughs not only increase the comfort and durability of shoes but also cater to the growing consumer demand for sustainable and high-performance products. Additionally, the rise of e-commerce platforms has made medical footwear more accessible, giving consumers the ability to shop online for products that meet their specific needs. The growing awareness of foot health and the importance of preventative care is further driving the market, particularly as more people look for footwear that offers added support and protection to avoid chronic conditions.

The medical footwear market is segmented into different product types, including shoes, sandals, and other footwear. The shoes segment alone was valued at USD 6 billion in 2024. This segment is particularly benefiting from the increasing prevalence of chronic health conditions such as diabetes and arthritis, which often result in foot complications. With foot health becoming an increasingly important aspect of overall well-being, consumers are gravitating toward shoes that offer optimal cushioning, arch support, and protection. The growing emphasis on prevention and comfort has further amplified demand for shoes specifically designed to alleviate pain and support foot health.

When it comes to distribution channels, the medical footwear market is split between online and offline sales. In 2024, the offline segment held a dominant 73.1% market share. Physical retail stores continue to thrive in the medical footwear sector because they offer a personalized shopping experience, allowing customers to try on shoes for proper fit and comfort-a crucial factor when purchasing medical footwear. Many brick-and-mortar stores also employ knowledgeable staff who can guide customers through the selection process, ensuring they find the right product for their specific foot issues. This hands-on approach builds trust and encourages repeat business, making the offline channel a strong player in the market.

The U.S. medical footwear market is also experiencing significant growth, valued at USD 2.6 billion in 2024. The prevalence of chronic diseases such as diabetes and obesity, which contribute to foot problems, has fueled the demand for specialized footwear. Additionally, the aging U.S. population is more prone to foot issues, further boosting market growth. With an increasing number of individuals seeking comfort and medical support in their footwear, the U.S. remains a key player in this rapidly expanding market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Supplier landscape
• 3.3 Profit margin analysis
• 3.4 Key news & initiatives
• 3.5 Regulatory landscape
• 3.6 Impact forces
  • 3.6.1 Growth drivers
    • 3.6.1.1 Rising prevalence of foot-related disorders
    • 3.6.1.2 Growing aging population
    • 3.6.1.3 Technological advancements in footwear design
  • 3.6.2 Industry pitfalls & challenges
    • 3.6.2.1 High cost of medical footwear
    • 3.6.2.2 Lack of awareness in developing regions
• 3.7 Growth potential analysis
• 3.8 Raw material analysis
• 3.9 Consumer buying behavior analysis
  • 3.9.1 Demographic trends
  • 3.9.2 Factors affecting buying decision
  • 3.9.3 Consumer product adoption
  • 3.9.4 Preferred distribution channel
  • 3.9.5 Preferred price range
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product Type, 2021-2034 (USD Billion) (Thousand Units)

• 5.1 Key trends
• 5.2 Shoes
• 5.3 Sandals
• 5.4 Others

Chapter 6 Market Estimates & Forecast, By End Use, 2021-2034 (USD Billion) (Thousand Units)

• 6.1 Key trends
• 6.2 Men
• 6.3 Women

Chapter 7 Market Estimates & Forecast, By Application, 2021-2034 (USD Billion) (Thousand Units)

• 7.1 Key trends
• 7.2 Diabetic shoes
• 7.3 Arthritis shoes
• 7.4 Bunions & hallux valgus shoes
• 7.5 Flat feet shoes
• 7.6 Others

Chapter 8 Market Estimates & Forecast, By Price, 2021-2034 (USD Billion) (Thousand Units)

• 8.1 Key trends
• 8.2 Less than 50 USD
• 8.3 50-100 USD
• 8.4 Above 100 USD

Chapter 9 Market Estimates & Forecast, By Distribution Channel, 2021-2034 (USD Billion) (Thousand Units)

• 9.1 Key trends
• 9.2 Online
• 9.3 Offline

Chapter 10 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion) (Thousand Units)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 UK
  • 10.3.2 Germany
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 South Korea
  • 10.4.5 Australia
  • 10.4.6 Malaysia
  • 10.4.7 Indonesia
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
• 10.6 MEA
  • 10.6.1 UAE
  • 10.6.2 Saudi Arabia
  • 10.6.3 South Africa

Chapter 11 Company Profiles

• 11.1 Aetrex Worldwide, Inc.
• 11.2 Clearwell Mobility Ltd
• 11.3 DARCO International, Inc.
• 11.4 Duna Srl
• 11.5 Dr. Comfort
• 11.6 Dr. Foot Inc.
• 11.7 Drewshoe, Incorporated
• 11.8 Foot Shop Limited
• 11.9 Gravity Defyer Corp.
• 11.10 Horng Shin Footwear Co.
• 11.11 Kinetec Medical Products Ltd
• 11.12 Mephisto
• 11.13 New Balance
• 11.14 Orthofeet Inc.
• 11.15 Watts Footwear